Mahmood Timbo
Medical · Los Angeles, CANPI 1881736452
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $849 and has fallen 64.2% since, to $304 in 2025.
Across 115 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$482
- Otsuka America Pharmaceutical, Inc.$354
- GSK$226
- Lilly USA, LLC$180
- Sunovion Pharmaceuticals Inc.$145
- Novo Nordisk$102
- plus $716 from 19 others
What the payments were for
- Food & beverage$2,205100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 20 | $482 |
| Otsuka America Pharmaceutical, Inc. | 27 | $354 |
| GSK | 13 | $226 |
| Lilly USA, LLC | 7 | $180 |
| Sunovion Pharmaceuticals Inc. | 11 | $145 |
| Novo Nordisk | 6 | $102 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $100 |
| Johnson & Johnson | 3 | $99 |
| Lundbeck LLC | 3 | $75 |
| Sumitomo Pharma America, Inc. | 3 | $68 |
| Bayer | 2 | $53 |
| Alkermes, Inc. | 2 | $45 |
| Redhill Biopharma Inc. | 1 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Gilead | 1 | $28 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Merck | 1 | $19 |
| Mylan Specialty L.p. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Pfizer | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
How this compares
$2,205 in reported general payments places this provider in the 75th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $387 |
| Losartan Potassium | 17 | $348 |
| Azithromycin | 97 | $264 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 40 | $259 |
| Lisinopril | 19 | $242 |
| Hydroxyzine Hcl | 24 | $164 |
| Gabapentin | 16 | $153 |
| Simvastatin | 14 | $135 |
| Atorvastatin Calcium | 14 | $122 |
| Amlodipine Besylate | 16 | $120 |
| Acyclovir | 15 | $116 |
| Omeprazole | 24 | $111 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $93 |
| Cephalexin | 18 | $90 |
| Methylprednisolone | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other medical in Los Angeles
- Jeffrey BonnaudLos Angeles$314K
- Kenny Davis TrinidadLos Angeles$99K
- Cheiny ShiauLos Angeles$86K
- Xochitl RentelnLos Angeles$38K
- Charlotte CarlsonLos Angeles$30K
- Dorna YaghoobzadehLos Angeles$18K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Ana TorresLaguna Beach$229K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.